Review
Fast Facts
Contact Info and Support
Traffic information
| Category | Metrics | Meaning |
|---|---|---|
| Ratings | Global Rank | - |
| Country Code | - | |
| Country Rank | - | |
| Category Rank | - | |
| Engagement metrics | Visits | 0 |
| Bounce Rate | 0 | |
| Pageviews per Visit | 0 | |
| Avg. Visit Duration | 0 | |
| Estimated monthly visits | October 2025 | 0 |
| November 2025 | 0 | |
| December 2025 | 0 | |
| Traffic sources | Social | - |
| Paid Referrals | - | |
| - | ||
| Referrals | - | |
| Search | - | |
| Direct | - | |
| Top keywords | avantbroker | 190 ◦ $0 |
About AvantGardeFx
AvantGardeFX operates under the trading name of Pure M Global LTD, incorporated in Vanuatu and claiming to be regulated by the Vanuatu Financial Services Commission (VFSC) under license number 14801, though this regulatory status is unverified in the VFSC register.
The broker offers trading via MetaTrader 4 and MetaTrader 5 platforms, supports over 85 forex pairs, CFDs on metals, energy, indices, stocks and cryptocurrencies, and provides account types including Standard, Professional, and VIP. Maximum leverage offered is up to 1:400; minimum live account deposit ranges from $500 to €1,000, depending on source.
Client funds are claimed to be held in segregated European bank accounts or with FCA‑regulated liquidity providers through Etana Custody, with insurance coverage provided by Falcon Insurance up to USD 500,000 aggregate and USD 50,000 per claim.
Pros and cons
Pros
- Access to MT4 and MT5 platforms and a wide range of trading instruments including forex, CFDs, metals, energies, indices, stocks, and cryptos.
- High maximum leverage of up to 1:400.
- Segregated fund claims via Etana Custody and insurance coverage by Falcon Insurance.
Cons
- No verified regulation; VFSC licensing is unconfirmed and not listed in official registry, posing significant regulatory risk.
- Multiple external reviews flag high risks and lack of credible regulatory protection.
- Contradictory information exists regarding minimum deposit (from $500 to €1,000), and the regulatory claims lack corroboration.













